+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

mRNA Therapeutics Market Report 2025

  • PDF Icon

    Report

  • 200 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 5997459
This mRNA Therapeutics market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The mRNA therapeutics market size has grown steadily in recent years. It will grow from $34.76 billion in 2024 to $36.25 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to increasing financial support for the creation of efficient pharmaceuticals and vaccines, the expansion of federal programs dedicated to advancing RNA-based medicines heightened awareness regarding rare genetic diseases, and a rise in the number of clinical trials.

The mRNA therapeutics market size is expected to see steady growth in the next few years. It will grow to $42.23 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to the growing number of infectious diseases, the increasing number of patients visiting hospitals and clinics, expanding applications of mRNA therapeutics, growing demand for personalized and precision medicine, favorable regulatory environments, and accelerated approval pathways. Major trends in the forecast period include advancements in mRNA delivery technologies, rapid development and adaptation of mRNA vaccines, the emergence of self-amplifying mRNA (saRNA) platforms, the scalability and flexibility of mRNA manufacturing, and the development of novel mRNA modifications.

The mRNA therapeutics market is poised for growth due to the increasing prevalence of long-lasting and communicable diseases. These diseases, which endure for extended periods and can be transmitted between individuals, include conditions such as tuberculosis, HIV/AIDS, and hepatitis. Factors contributing to their rise include global travel and inadequate healthcare infrastructure, which facilitate disease spread and hinder effective management. mRNA therapeutics are pivotal in combating such diseases by swiftly enabling the body to produce proteins that enhance immune responses, thereby accelerating the development of vaccines and treatments. For example, in 2022, the number of people in England living with diagnosed HIV and receiving care rose to 94,397, a 3% increase from 2021, highlighting the need for effective therapeutic advancements.

Leading companies in the mRNA therapeutics market are concentrating on pioneering solutions, such as mRNA-based booster vaccines, to bolster immunity against evolving viral variants. These vaccines utilize messenger RNA (mRNA) technology to extend and enhance immunity against specific pathogens, particularly following initial vaccination series. For instance, Gennova Biopharmaceuticals Ltd. launched India's first indigenous mRNA-based Omicron-specific booster vaccine, GEMCOVAC-OM, in June 2023. Designed to combat the Omicron variant of SARS-CoV-2, GEMCOVAC-OM is thermostable and can be administered without needle injection, facilitating easy deployment in India's last-mile regions. Clinical studies have shown significantly heightened immune responses compared to other vaccines, underscoring the efficacy of variant-specific approaches.

In May 2022, OPKO Health Inc., a US-based pharmaceutical company, acquired ModeX Therapeutics Inc. for around $300 million. The acquisition is designed to strengthen OPKO Health's oncology and infectious disease portfolio by incorporating ModeX's groundbreaking immune therapies. This move aims to expand OPKO’s product pipeline and capitalize on synergies to accelerate development in crucial therapeutic areas. ModeX Therapeutics Inc. is a US-based biotechnology company specializing in mRNA therapeutics.

Major companies operating in the mRNA therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG.

North America was the largest region in the mRNA therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mRNA therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Messenger RNA (mRNA) therapeutics involve utilizing mRNA molecules to prompt cells to produce therapeutic proteins within the body, aimed at preventing, treating, or curing diseases by facilitating the production of specific proteins necessary for therapeutic benefits.

The primary products in mRNA therapeutics include vaccines and drugs. mRNA vaccines instruct cells via mRNA to generate proteins that stimulate an immune response against targeted diseases. These vaccines find applications across various fields such as infectious diseases, oncology, rare genetic diseases, respiratory illnesses, among others. End users include hospitals, clinics, research organizations, and other healthcare providers.

The mRNA therapeutics market research report is one of a series of new reports that provides mRNA therapeutics market statistics, including mRNA therapeutics industry global market size, regional shares, competitors with a mRNA therapeutics market share, detailed mRNA therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the mRNA therapeutics industry. This mRNA therapeutics market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mRNA therapeutics market consists of revenues earned by entities by providing services such as vaccine development, protein replacement therapies, gene editing, monoclonal antibody production, and cancer treatment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. mRNA Therapeutics Market Characteristics3. mRNA Therapeutics Market Trends and Strategies4. mRNA Therapeutics Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
5. Global mRNA Therapeutics Growth Analysis and Strategic Analysis Framework
5.1. Global mRNA Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis of End Use Industries
5.3. Global mRNA Therapeutics Market Growth Rate Analysis
5.4. Global mRNA Therapeutics Historic Market Size and Growth, 2019-2024, Value ($ Billion)
5.5. Global mRNA Therapeutics Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Billion)
5.6. Global mRNA Therapeutics Total Addressable Market (TAM)
6. mRNA Therapeutics Market Segmentation
6.1. Global mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vaccines
  • Drugs
6.2. Global mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Oncology
  • Rare Genetic Diseases
  • Respiratory Diseases
  • Other Applications
6.3. Global mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals and Clinics
  • Research Organizations
  • Other End Uses
6.4. Global mRNA Therapeutics Market, Sub-Segmentation of Vaccines, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease Vaccines
  • Cancer Vaccines
  • Other Therapeutic Vaccines
6.5. Global mRNA Therapeutics Market, Sub-Segmentation of Drugs, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology Drugs
  • Cardiovascular Drugs
  • Autoimmune Disease Drugs
  • Other mRNA-Based Drugs
7. mRNA Therapeutics Market Regional and Country Analysis
7.1. Global mRNA Therapeutics Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global mRNA Therapeutics Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific mRNA Therapeutics Market
8.1. Asia-Pacific mRNA Therapeutics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China mRNA Therapeutics Market
9.1. China mRNA Therapeutics Market Overview
9.2. China mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India mRNA Therapeutics Market
10.1. India mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan mRNA Therapeutics Market
11.1. Japan mRNA Therapeutics Market Overview
11.2. Japan mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia mRNA Therapeutics Market
12.1. Australia mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia mRNA Therapeutics Market
13.1. Indonesia mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea mRNA Therapeutics Market
14.1. South Korea mRNA Therapeutics Market Overview
14.2. South Korea mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe mRNA Therapeutics Market
15.1. Western Europe mRNA Therapeutics Market Overview
15.2. Western Europe mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK mRNA Therapeutics Market
16.1. UK mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany mRNA Therapeutics Market
17.1. Germany mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France mRNA Therapeutics Market
18.1. France mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy mRNA Therapeutics Market
19.1. Italy mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain mRNA Therapeutics Market
20.1. Spain mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe mRNA Therapeutics Market
21.1. Eastern Europe mRNA Therapeutics Market Overview
21.2. Eastern Europe mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia mRNA Therapeutics Market
22.1. Russia mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America mRNA Therapeutics Market
23.1. North America mRNA Therapeutics Market Overview
23.2. North America mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA mRNA Therapeutics Market
24.1. USA mRNA Therapeutics Market Overview
24.2. USA mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada mRNA Therapeutics Market
25.1. Canada mRNA Therapeutics Market Overview
25.2. Canada mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America mRNA Therapeutics Market
26.1. South America mRNA Therapeutics Market Overview
26.2. South America mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil mRNA Therapeutics Market
27.1. Brazil mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East mRNA Therapeutics Market
28.1. Middle East mRNA Therapeutics Market Overview
28.2. Middle East mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa mRNA Therapeutics Market
29.1. Africa mRNA Therapeutics Market Overview
29.2. Africa mRNA Therapeutics Market, Segmentation by Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa mRNA Therapeutics Market, Segmentation by Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa mRNA Therapeutics Market, Segmentation by End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. mRNA Therapeutics Market Competitive Landscape and Company Profiles
30.1. mRNA Therapeutics Market Competitive Landscape
30.2. mRNA Therapeutics Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Sanofi AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
31. mRNA Therapeutics Market Other Major and Innovative Companies
31.1. Hoffmann-La Roche AG
31.2. Moderna Therapeutics Inc.
31.3. BioNTech SE
31.4. Vertex Pharmaceuticals Incorporated
31.5. Catalent Inc.
31.6. Alnylam Pharmaceuticals Inc.
31.7. Sarepta Therapeutics Inc.
31.8. Arcturus Therapeutics Holdings Inc.
31.9. CureVac N.V.
31.10. Ethris GMBH
31.11. eTheRNA immunotherapies NV
31.12. in-Cell-Art S.a.S.
31.13. Nutcracker Therapeutics Inc.
31.14. SCM LifeScience Co. Ltd.
31.15. Suzhou Abogen Biosciences Co. Ltd.
32. Global mRNA Therapeutics Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the mRNA Therapeutics Market34. Recent Developments in the mRNA Therapeutics Market
35. mRNA Therapeutics Market High Potential Countries, Segments and Strategies
35.1 mRNA Therapeutics Market in 2029 - Countries Offering Most New Opportunities
35.2 mRNA Therapeutics Market in 2029 - Segments Offering Most New Opportunities
35.3 mRNA Therapeutics Market in 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

mRNA Therapeutics Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mrna therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for mrna therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mrna therapeutics market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: Vaccines; Drugs
2) By Application: Infectious Diseases; Oncology; Rare Genetic Diseases; Respiratory Diseases; Other Applications
3) By End Use: Hospitals and Clinics; Research Organizations; Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines; Cancer Vaccines; Other Therapeutic Vaccines
2) By Drugs: Oncology Drugs; Cardiovascular Drugs; Autoimmune Disease Drugs; Other mRNA-Based Drugs

Key Companies Mentioned: Pfizer Inc.; Novartis AG; Sanofi AG; AstraZeneca plc; GlaxoSmithKline plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

The major companies featured in this mRNA Therapeutics market report include:
  • Pfizer Inc.
  • Novartis AG
  • Sanofi AG
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Hoffmann-La Roche AG
  • Moderna Therapeutics Inc
  • BioNTech SE
  • Vertex Pharmaceuticals Incorporated
  • Catalent Inc
  • Alnylam Pharmaceuticals Inc
  • Sarepta Therapeutics Inc
  • Arcturus Therapeutics Holdings Inc
  • CureVac N.V
  • Ethris GMBH
  • eTheRNA immunotherapies NV
  • In-Cell-Art S.A.S.
  • Nutcracker Therapeutics Inc
  • SCM LifeScience Co Ltd
  • Suzhou Abogen Biosciences Co Ltd
  • Tiba Biotech LLC
  • CSPC Pharmaceutical Group
  • CRISPR Therapeutics AG

Table Information